List of Excipients in API clofazimine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing clofazimine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | LAMPRENE | clofazimine | 0078-1049 | 4-ACETYLANISOLE | |
| Novartis Pharmaceuticals Corporation | LAMPRENE | clofazimine | 0078-1049 | ANHYDROUS CITRIC ACID | |
| Novartis Pharmaceuticals Corporation | LAMPRENE | clofazimine | 0078-1049 | BUTYLATED HYDROXYTOLUENE | |
| Novartis Pharmaceuticals Corporation | LAMPRENE | clofazimine | 0078-1049 | ETHYL VANILLIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for clofazimine
Excipient focus: 4-ACETYLANISOLE
clofazimine drug variants containing 4-ACETYLANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing 4-ACETYLANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
clofazimine drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
clofazimine drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYL VANILLIN
clofazimine drug variants containing ETHYL VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing ETHYL VANILLIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLPARABEN SODIUM
clofazimine drug variants containing ETHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing ETHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
clofazimine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
clofazimine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
clofazimine drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
clofazimine drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED RAPESEED OIL
clofazimine drug variants containing HYDROGENATED RAPESEED OIL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing HYDROGENATED RAPESEED OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED SOYBEAN OIL
clofazimine drug variants containing HYDROGENATED SOYBEAN OIL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing HYDROGENATED SOYBEAN OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
clofazimine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN SODIUM
clofazimine drug variants containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SOYBEAN LECITHIN
clofazimine drug variants containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SOYBEAN OIL
clofazimine drug variants containing SOYBEAN OIL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing SOYBEAN OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
clofazimine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: YELLOW WAX
clofazimine drug variants containing YELLOW WAX
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | clofazimine | 0078-1049 |
| >Company | >Ingredient | >NDC |
clofazimine drug variants not containing YELLOW WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links